AI-enhanced surgical robotics is advancing beyond teleoperation toward AI-assisted and eventually autonomous surgery. Intuitive Surgical's da Vinci 5 system, launched in 2025, integrates force feedback and AI-powered real-time tissue analysis for the first time. Vicarious Surgical is developing miniaturized robots that enter through a single incision. Verb Surgical (Johnson & Johnson) combines surgical robotics with machine learning from thousands of recorded procedures.
AI augmentation enables surgeons to operate with superhuman precision: real-time identification of nerves and blood vessels, prediction of tissue behavior, and recommendations based on analysis of millions of similar procedures. The next frontier is autonomous suturing and tissue manipulation, where the robot executes specific surgical steps under surgeon supervision.
Intuitive Surgical dominates the US market with over 9,000 da Vinci systems installed, giving it an enormous data advantage — every procedure generates training data for AI models. The strategic implication is that surgical expertise, traditionally limited by human training bottlenecks, could become scalable through AI — enabling expert-level surgery in underserved areas worldwide.